Press Releases

WASHINGTON, April 4, 2019 /PRNewswire/ -- MCRA, LLC has announced its role in the successful granting of the first De Novo for a device in

WASHINGTON, March 7, 2019 /PRNewswire/ --  MCRA, LLC announced today its role in the successful Premarket Approval (PMA) application decision by th

WASHINGTON, March 5, 2019 /PRNewswire/ -- MCRA, LLC, a leading medical device consulting firm and clinical research organization (CRO) that integra

The session aimed to collaboratively explore U.S. device regulations and offer high-level knowledge about the FDA review process.

WASHINGTON, Jan.

SANUWAVE retained MCRA in January of 2015 to lead interactions and correspondence with the FDA for the dermaPACE.

NEW YORK, Dec.

The Experiential Learning Program (ELP) is a learning opportunity designed to help all levels of FDA within the Center for Devices and Radiological

The Experiential Learning Program (ELP) is a program designed to help all levels of FDA within the Center for Devices and Radiological Health (CDRH

As the medical device market grows due to continued innovation and changing demographics, it is imperative for industry to be able to successfully

Mr.

WASHINGTON, Feb.